Home » Stocks » Invacare

Invacare Corporation (IVC)

Stock Price: $6.80 USD -0.15 (-2.16%)
Updated Aug 14, 2020 4:00 PM EDT - Market closed

Stock Price Chart

Key Info

Market Cap 234.01M
Revenue (ttm) 883.43M
Net Income (ttm) -42.61M
Shares Out 34.41M
EPS (ttm) -1.27
PE Ratio n/a
Forward PE n/a
Dividend $0.05
Dividend Yield 0.74%

Stock Quote

Trading Day Aug 14, 2020
Last Price $6.80
Previous Close $6.95
Change ($) -0.15
Change (%) -2.16%
Day's Open 6.86
Day's Range 6.70 - 6.97
Day's Volume 200,592
52-Week Range 3.90 - 11.63

More Stats

Market Cap 234.01M
Enterprise Value 430.55M
Earnings Date (est) Nov 10, 2020
Ex-Dividend Date Apr 2, 2020
Shares Outstanding 34.41M
Float 30.74M
EPS (basic) -1.26
EPS (diluted) -1.27
FCF / Share 0.07
Dividend $0.05
Dividend Yield 0.74%
Earnings Yield n/a
FCF Yield 0.96%
Payout Ratio n/a
Shares Short 5.06M
Short Ratio 17.38
Short % of Float 17.96%
Beta 1.22
PE Ratio n/a
Forward PE n/a
P/FCF Ratio 104.42
PS Ratio 0.26
PB Ratio 0.81
Revenue 883.43M
Operating Income -4.20M
Net Income -42.61M
Free Cash Flow 2.24M
Net Cash -196.54M
Net Cash / Share -5.71
Gross Margin 29.66%
Operating Margin -0.48%
Profit Margin -4.80%
FCF Margin 0.25%
ROA 0.65%
ROE -13.44%
ROIC n/a
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (0)

Buy 0
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: n/a

Price Target

$14.33*
(110.74% upside)
Low
11.0
Current: $6.80
High
17.0
Target: 14.33
*Average 12-month price target from 3 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year2019201820172016201520142013201220112010
Revenue9289729661,0471,1421,2701,3351,4161,4821,425
Revenue Growth-4.56%0.61%-7.73%-8.3%-10.06%-4.82%-5.74%-4.49%4.06%-
Gross Profit262268269284313347367427474472
Operating Income-10.41-18.29-40.16-22.60-7.79-58.83-40.778.4420.6187.14
Net Income-53.33-43.92-76.54-42.86-26.19-56.0733.051.83-4.1125.34
Shares Outstanding33.5933.1232.7532.4732.1732.0131.9231.6431.9632.39
Earnings Per Share-1.59-1.33-2.34-1.32-0.81-1.751.030.06-0.130.78
EPS Growth------1616.67%---
Dividend Per Share0.050.050.040.050.050.050.060.030.060.04
Dividend Growth-1.96%30.77%-22%-1.96%0%-7.27%66.67%-42.11%62.86%-
Operating Cash Flow2.74-46.42-25.77-56.61-5.388.8910.0562.2999.08122
Capital Expenditures-10.80-6.26-14.20-10.1115.60-9.81-13.27-19.93-22.10-17.32
Free Cash Flow-8.06-52.68-39.97-66.7210.22-0.91-3.2242.3676.98105
Cash & Equivalents80.0611717712460.0638.9329.7938.7934.9248.46
Total Debt26725624316147.1220.3345.29235265246
Net Cash / Debt-187-139-66.92-37.1212.9418.60-15.50-196-231-198
Assets8528861,0669048389641,0961,2621,2811,280
Liabilities544527643481375398426641655628
Book Value309359423422463565671621627652
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Invacare Corporation
Country United States
Employees 3,900
CEO Matthew E. Monaghan

Stock Information

Ticker Symbol IVC
Stock Exchange New York Stock Exchange
Sector Healthcare
Industry Medical Devices
Unique Identifier NYSE: IVC

Description

Invacare Corporation, together with its subsidiaries, designs, manufactures, distributes, and exports medical equipment for use in home health care, retail, and extended care markets worldwide. The company operates through Europe, North America/Home Medical Equipment, Institutional Products Group, and the Asia/Pacific segments. It offers mobility and seating products, such as power wheelchairs under the Invacare TDX brand; custom manual wheelchairs under the Invacare, Invacare Top End, and Küschall brand names; and seating and positioning products. The company also provides lifestyle products, including pressure relieving overlays and mattress systems under the Invacare Softform and microAIR brands; safe resident handling products; residential care and home beds and bed accessories, and manual wheelchairs under the Invacare brand name; and personal care products. In addition, the company offers respiratory therapy products comprising stationary oxygen concentrators under the Platinum and Perfecto2 brands; portable oxygen concentrators; and Invacare HomeFill oxygen systems. Further, it sells and distributes healthcare furnishings consisting of long-term care beds, case goods, safe patient handling equipment, and other equipment and accessories for long-term care customers. It sells its products primarily to home medical equipment providers through retail and e-commerce channels, as well as to residential care operators, distributors, and government health service customers through its sales force, independent manufacturers' representatives, and distributors. Invacare Corporation was founded in 1885 and is headquartered in Elyria, Ohio.